Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 34, 2013, Pages

  Gill, David J ^a   Tham, Keit Min ^a   Chia, Joanne ^a   Wang, Shyi Chyi ^a   Steentoft, Catharina ^b   Clausen, Henrik ^b   Bard Chapeau, Emilie A ^a   Bard, Frederic A ^a,c  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

C1GalT; COPI; Invasion; Src; Thomsen Friedenreich antigen

Indexed keywords

LECTIN; GLYCOSYLTRANSFERASE; N ACETYLGALACTOSAMINE; THOMSEN-FRIEDENREICH ANTIGEN; TN ANTIGEN; TUMOR ANTIGEN;

ARTICLE; BREAST TUMOR; CANCER CELL; CANCER CELL CULTURE; CARCINOMA CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HUMAN; IN VITRO STUDY; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL MOTION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GOLGI COMPLEX; KAPLAN MEIER METHOD; METABOLISM; MOLECULAR CLONING; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR INVASION; WESTERN BLOTTING;

ACETYLGALACTOSAMINE; ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CLONING, MOLECULAR; ENDOPLASMIC RETICULUM; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; GLYCOSYLTRANSFERASES; GOLGI APPARATUS; HUMANS; KAPLAN-MEIER ESTIMATE; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASMS;

EID: 84882804313     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1305269110     Document Type: Article

References (47)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144 (5):646-674.
2. Teodorczyk M, Martin-Villalba A (2010) Sensing invasion: Cell surface receptors driving spreading of glioblastoma. J Cell Physiol 222(1):1-10.
3. Valastyan S, Weinberg RA (2011) Tumor metastasis: Molecular insights and evolving paradigms. Cell 147(2):275-292.
4. Lau KS, Dennis JW (2008) N-Glycans in cancer progression. Glycobiology 18(10):750-760.
5. Ungar D (2009) Golgi linked protein glycosylation and associated diseases. Semin Cell Dev Bioly 20(7):762-769.
6. Laack E, et al. (2002) Lectin histochemistry of resected adenocarcinoma of the lung: Helix pomatia agglutinin binding is an independent prognostic factor. Am J Pathol 160(3):1001-1008.
7. Konno A, Hoshino Y, Terashima S, Motoki R, Kawaguchi T (2002) Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin Exp Metastasis 19(1):61-70.
8. Springer GF (1984) T and Tn, general carcinoma autoantigens. Science (New York, NY) 224(4654):1198-1206.
9. Newman RA, Uhlenbruck GG (1977) Investigation into the occurrence and structure of lectin receptors on human and bovine erythrocytes milk fat globule and lymphocyte plasma-membrane glycoproteins. Eur J Biochem 76(1):149-155.
10. Tollefsen SE, Kornfeld R (1983) The B4 lectin from Vicia villosa seeds interacts with Nacetylgalactosamine residues alpha-linked to serine or threonine residues in cell surface glycoproteins. J Biol Chem 258(8):5172-5176.
11. Bennett EP, et al. (2012) Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22(6):736-756.
12. Steentoft C, et al. (2011) Mining the O-glycoproteome using zinc-finger nucleaseglycoengineered SimpleCell lines. Nat Methods 8(11):977-982.
13. Steentoft C, et al. (2013) Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J 32(10):1478-1488.
14. Ten Hagen KG, Fritz TA, Tabak LA (2003) All in the family: The UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13(1):1R-16R.
15. Wandall HH, et al. (2007) The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: Lectin binding to GalNAcglycopeptide substrates is required for high density GalNAc-O-glycosylation. Glycobiology 17(4):374-387.
16. Pedersen JW, et al. (2011) Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity. J Biol Chem 286(37):32684-32696.
17. Inoue M, et al. (2001) High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferase-3 in colonic adenocarcinoma extracts. Cancer Res 61(3):950-956.
18. Röttger S, et al. (1998) Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. J Cell Sci 111(Pt 1):45-60.
19. Pavelka M, Ellinger A (1985) Localization of binding sites for concanavalin A, Ricinus communis I and Helix pomatia lectin in the Golgi apparatus of rat small intestinal absorptive cells. J Histochem Cytochem 33(9):905-914.
20. Ju T, Brewer K, D'Souza A, Cummings RD, Canfield WM(2002) Cloning and expression of human core 1 beta1,3-galactosyltransferase. J Biol Chem 277(1):178-186.
21. Ju T, Cummings RD (2002) A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci USA 99(26): 16613-16618.
22. Stanley P (2011) Golgi glycosylation. Cold Spring Harb Perspect Biol 3(4):pii a005199.
23. Thurnher M, Clausen H, Fierz W, Lanzavecchia A, Berger EG (1992) T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability. Eur J Immunol 22(7):1835-1842.
24. Ju T, Cummings RD (2005) Protein glycosylation: Chaperone mutation in Tn syndrome. Nature 437(7063):1252.
25. Crew VK, et al. (2008) New mutations in C1GALT1C1 in individuals with Tn positive phenotype. Br J Haematol 142(4):657-667.
26. Ju T, Otto VI, Cummings RD (2011) The Tn antigen-structural simplicity and biological complexity. Angew Chem Int Ed Engl 50(8):1770-1791.
27. Lo-Man R, et al. (2004) A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res 64(14):4987-4994.
28. Miles D, et al.; Theratopě Study Group (2011) Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer. Oncologist 16(8):1092-1100.
29. Ju T, et al. (2008) Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res 68(6):1636-1646.
30. Gill DJ, Chia J, Senewiratne J, Bard F (2010) Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes. J Cell Biol 189(5):843-858.
31. High S, Lecomte FJ, Russell SJ, Abell BM, Oliver JD (2000) Glycoprotein folding in the endoplasmic reticulum: A tale of three chaperones? FEBS Lett 476(1-2):38-41.
32. Yuan M, et al. (1986) Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res 46(9):4841-4847.
33. Cheng AS, et al. (2008) Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res 68(6):1786-1796.
34. Chen DT, et al. (2010) Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat 119(2):335-346.
35. Humphries MJ, Olden K, Yamada KM (1986) A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 233(4762): 467-470.
36. Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2(2):91-100.
37. Lelekakis M, et al. (1999) A novel orthotopic model of breast cancer metastasis to bone. Clinical & experimental metastasis, 17(2),163-170.
38. Lauc G, Rudan I, Campbell H, Rudd PM (2010) Complex genetic regulation of protein glycosylation. Mol Biosyst 6(2):329-335.
39. Welinder C, Baldetorp B, Borrebaeck C, Fredlund BM, Jansson B (2011) A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity. Glycobiology 21 (8):1097-1107.
40. Heimburg-Molinaro J, et al. (2011) Cancer vaccines and carbohydrate epitopes. Vaccine 29(48):8802-8826.
41. Normanno N, et al. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366(1):2-16.
42. Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276-1312.
43. Guarino M (2010) Src signaling in cancer invasion. J Cell Physiol 223(1):14-26.
44. Chia J, et al. (2012) RNAi screening reveals a large signaling network controlling the Golgi apparatus in human cells. Mol Syst Biol 8:629.
45. Schjoldager KT, et al. (2011) A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing. J Biol Chem 286 (46):40122-40132.
46. Schjoldager KT, Clausen H (2012) Site-specific protein O-glycosylation modulates proprotein processing-Deciphering specific functions of the large polypeptide GalNAc-transferase gene family. Biochim Biophys Acta 1820(12):2079-2094.
47. Gerken TA (2004) Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects. Biochemistry 43(14):4137-4142.